{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T16:59:16Z","timestamp":1761238756883,"version":"3.37.3"},"reference-count":43,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2020,7,27]],"date-time":"2020-07-27T00:00:00Z","timestamp":1595808000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["P30DA035778A1"],"award-info":[{"award-number":["P30DA035778A1"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,3,22]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Given the scale and rapid spread of the coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), there is an urgent need for medicines that can help before vaccines are available. In this study, we present a viral-associated disease-specific chemogenomics knowledgebase (Virus-CKB) and apply our computational systems pharmacology-target mapping to rapidly predict the FDA-approved drugs which can quickly progress into clinical trials to meet the urgent demand of the COVID-19 outbreak. Virus-CKB reuses the underlying platform of our DAKB-GPCRs but adds new features like multiple-compound support, multi-cavity protein support and customizable symbol display. Our one-stop computing platform describes the chemical molecules, genes and proteins involved in viral-associated diseases regulation. To date, Virus-CKB archived 65 antiviral drugs in the market, 107 viral-related targets with 189 available 3D crystal or cryo-EM structures and 2698 chemical agents reported for these target proteins. Moreover, Virus-CKB is implemented with web applications for the prediction of the relevant protein targets and analysis and visualization of the outputs, including HTDocking, TargetHunter, BBB predictor, NGL Viewer, Spider Plot, etc. The Virus-CKB server is accessible at https:\/\/www.cbligand.org\/g\/virus-ckb.<\/jats:p>","DOI":"10.1093\/bib\/bbaa155","type":"journal-article","created":{"date-parts":[[2020,6,18]],"date-time":"2020-06-18T19:11:28Z","timestamp":1592507488000},"page":"882-895","source":"Crossref","is-referenced-by-count":29,"title":["Virus-CKB: an integrated bioinformatics platform and analysis resource for COVID-19 research"],"prefix":"10.1093","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6533-8932","authenticated-orcid":false,"given":"Zhiwei","family":"Feng","sequence":"first","affiliation":[{"name":"School of Pharmacy, University of Pittsburgh"}]},{"given":"Maozi","family":"Chen","sequence":"additional","affiliation":[{"name":"South China Agricultural University, China"}]},{"given":"Tianjian","family":"Liang","sequence":"additional","affiliation":[{"name":"Jiangnan University, China"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7461-3764","authenticated-orcid":false,"given":"Mingzhe","family":"Shen","sequence":"additional","affiliation":[{"name":"School of Pharmacy, University of Pittsburgh"}]},{"given":"Hui","family":"Chen","sequence":"additional","affiliation":[{"name":"School of Pharmacy, University of Pittsburgh"}]},{"given":"Xiang-Qun","family":"Xie","sequence":"additional","affiliation":[{"name":"School of Pharmacy and a Professor of Pharmaceutical Sciences"}]}],"member":"286","published-online":{"date-parts":[[2020,7,27]]},"reference":[{"key":"2021032314270801800_ref1","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"key":"2021032314270801800_ref2","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2008-3","article-title":"A new coronavirus associated with human respiratory disease in China","volume":"579","author":"Wu","year":"2020","journal-title":"Nature"},{"key":"2021032314270801800_ref3","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"2021032314270801800_ref4","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A novel coronavirus from patients with pneumonia in China, 2019","volume":"382","author":"Zhu","year":"2020","journal-title":"N Engl J Med"},{"key":"2021032314270801800_ref5","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(20)30251-8","article-title":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding","volume":"395","author":"Lu","year":"2020","journal-title":"Lancet"},{"key":"2021032314270801800_ref6","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1056\/NEJMoa2007016","article-title":"Compassionate use of Remdesivir for patients with severe Covid-19","volume":"382","author":"Grein","year":"2020","journal-title":"N Engl J Med"},{"key":"2021032314270801800_ref7","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1016\/S0140-6736(20)30304-4","article-title":"Baricitinib as potential treatment for 2019-nCoV acute respiratory disease","volume":"395","author":"Richardson","year":"2020","journal-title":"Lancet"},{"key":"2021032314270801800_ref8","doi-asserted-by":"crossref","first-page":"72","DOI":"10.5582\/bst.2020.01047","article-title":"Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies","volume":"14","author":"Gao","year":"2020","journal-title":"Biosci Trends"},{"key":"2021032314270801800_ref9","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1001\/jama.2020.2783","article-title":"Positive RT-PCR test results in patients recovered from COVID-19","volume":"323","author":"Lan","year":"2020","journal-title":"JAMA"},{"key":"2021032314270801800_ref10","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"N Engl J Med"},{"key":"2021032314270801800_ref11","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111634","article-title":"Discovery of dual-acting opioid ligand and TRPV1 antagonists as novel therapeutic agents for pain","volume":"182","author":"Lee","year":"2019","journal-title":"Eur J Med Chem"},{"key":"2021032314270801800_ref12","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.drudis.2012.01.003","article-title":"A series of case studies: practical methodology for identifying antinociceptive multi-target drugs","volume":"17","author":"Pang","year":"2012","journal-title":"Drug Discov Today"},{"key":"2021032314270801800_ref13","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41586-020-2180-5","article-title":"Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor","volume":"581","author":"Lan","year":"2020","journal-title":"Nature"},{"key":"2021032314270801800_ref14","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41586-020-2223-y","article-title":"Structure of M(pro) from COVID-19 virus and discovery of its inhibitors","volume":"582","author":"Jin","year":"2020","journal-title":"Nature"},{"key":"2021032314270801800_ref15","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1126\/science.abb7498","article-title":"Structure of the RNA-dependent RNA polymerase from COVID-19 virus","volume":"368","author":"Gao","year":"2020","journal-title":"Science"},{"key":"2021032314270801800_ref16","first-page":"00163 2020","article-title":"COVID-19 docking server: an interactive server for docking small molecules, peptides and antibodies against potential targets of COVID-19","author":"Kong","year":"2003","journal-title":"arXiv preprint arXiv"},{"key":"2021032314270801800_ref17","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/s41421-020-0153-3","article-title":"Network-based drug repurposing for novel coronavirus 2019-nCoV\/SARS-CoV-2","volume":"6","author":"Zhou","year":"2020","journal-title":"Cell Discovery"},{"key":"2021032314270801800_ref18","doi-asserted-by":"crossref","first-page":"3486","DOI":"10.1021\/acschemneuro.9b00109","article-title":"Computational systems pharmacology-target mapping for fentanyl-laced cocaine overdose","volume":"10","author":"Cheng","year":"2019","journal-title":"ACS Chem Nerosci"},{"key":"2021032314270801800_ref19","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1021\/acsomega.9b03960","article-title":"Insight into Ginkgo biloba L. extract on the improved spatial learning and memory by Chemogenomics knowledgebase, molecular docking, molecular dynamics simulation, and bioassay validations","volume":"5","author":"Chen","year":"2020","journal-title":"ACS Omega"},{"key":"2021032314270801800_ref20","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1021\/ci500004h","article-title":"AlzPlatform: an Alzheimer's disease domain-specific chemogenomics knowledgebase for polypharmacology and target identification research","volume":"54","author":"Liu","year":"2014","journal-title":"J Chem Inf Model"},{"key":"2021032314270801800_ref21","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1021\/acs.jcim.5b00748","article-title":"StemCellCKB: an integrated stem cell-specific chemogenomics knowledgebase for target identification and systems-pharmacology research","volume":"56","author":"Zhang","year":"2016","journal-title":"J Chem Inf Model"},{"key":"2021032314270801800_ref22","doi-asserted-by":"crossref","first-page":"33963","DOI":"10.1038\/srep33963","article-title":"Cardiovascular disease chemogenomics knowledgebase-guided target identification and drug synergy mechanism study of an herbal formula","volume":"6","author":"Zhang","year":"2016","journal-title":"Sci Rep"},{"key":"2021032314270801800_ref23","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1208\/s12248-012-9449-z","article-title":"TargetHunter: an in silico target identification tool for predicting therapeutic potential of small organic molecules based on chemogenomic database","volume":"15","author":"Wang","year":"2013","journal-title":"AAPS J"},{"key":"2021032314270801800_ref24","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1021\/acs.jcim.8b00623","article-title":"DAKB-GPCRs: an integrated computational platform for drug abuse related GPCRs","volume":"59","author":"Chen","year":"2019","journal-title":"J Chem Inf Model"},{"key":"2021032314270801800_ref25","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1758-2946-3-33","article-title":"Open babel: an open chemical toolbox","volume":"3","author":"O'Boyle","year":"2011","journal-title":"J Chem"},{"key":"2021032314270801800_ref26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1758-2946-2-1","article-title":"Molecular structure input on the web","volume":"2","author":"Ertl","year":"2010","journal-title":"J Chem"},{"key":"2021032314270801800_ref27","doi-asserted-by":"crossref","first-page":"e85678","DOI":"10.1371\/journal.pone.0085678","article-title":"Istar: a web platform for large-scale protein-ligand docking","volume":"9","author":"Li","year":"2014","journal-title":"PLoS One"},{"key":"2021032314270801800_ref28","doi-asserted-by":"crossref","first-page":"3755","DOI":"10.1093\/bioinformatics\/bty419","article-title":"NGL viewer: web-based molecular graphics for large complexes","volume":"34","author":"Rose","year":"2018","journal-title":"Bioinformatics (Oxford, England)"},{"key":"2021032314270801800_ref29","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1093\/nar\/gky092","article-title":"UniProt: the universal protein knowledgebase","volume":"46","author":"UniProt Consortium","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"2021032314270801800_ref30","doi-asserted-by":"crossref","first-page":"D464","DOI":"10.1093\/nar\/gky1004","article-title":"RCSB protein data Bank: biological macromolecular structures enabling research and education in fundamental biology, biomedicine, biotechnology and energy","volume":"47","author":"Burley","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"2021032314270801800_ref31","doi-asserted-by":"crossref","first-page":"D1121","DOI":"10.1093\/nar\/gkx1076","article-title":"Therapeutic target database update 2018: enriched resource for facilitating bench-to-clinic research of targeted therapeutics","volume":"46","author":"Li","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"2021032314270801800_ref32","first-page":"D1031","article-title":"Therapeutic target database 2020: enriched resource for facilitating research and early development of targeted therapeutics","volume":"48","author":"Wang","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"2021032314270801800_ref33","doi-asserted-by":"crossref","first-page":"D1128","DOI":"10.1093\/nar\/gkr797","article-title":"Therapeutic target database update 2012: a resource for facilitating target-oriented drug discovery","volume":"40","author":"Zhu","year":"2012","journal-title":"Nucleic Acids Res"},{"key":"2021032314270801800_ref34","doi-asserted-by":"crossref","first-page":"D787","DOI":"10.1093\/nar\/gkp1014","article-title":"Update of TTD: therapeutic target database","volume":"38","author":"Zhu","year":"2010","journal-title":"Nucleic Acids Res"},{"key":"2021032314270801800_ref35","doi-asserted-by":"crossref","first-page":"D1069","DOI":"10.1093\/nar\/gkv1230","article-title":"Therapeutic target database update 2016: enriched resource for bench to clinical drug target and targeted pathway information","volume":"44","author":"Yang","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"2021032314270801800_ref36","doi-asserted-by":"crossref","first-page":"D1118","DOI":"10.1093\/nar\/gkt1129","article-title":"Therapeutic target database update 2014: a resource for targeted therapeutics","volume":"42","author":"Qin","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"2021032314270801800_ref37","doi-asserted-by":"crossref","first-page":"D1100","DOI":"10.1093\/nar\/gkr777","article-title":"ChEMBL: a large-scale bioactivity database for drug discovery","volume":"40","author":"Gaulton","year":"2012","journal-title":"Nucleic Acids Res"},{"key":"2021032314270801800_ref38","doi-asserted-by":"crossref","first-page":"D1074","DOI":"10.1093\/nar\/gkx1037","article-title":"DrugBank 5.0: a major update to the DrugBank database for 2018","volume":"46","author":"Wishart","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"2021032314270801800_ref39","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1021\/ci100399j","article-title":"Ligand classifier of adaptively boosting ensemble decision stumps (LiCABEDS) and its application on modeling ligand functionality for 5HT-subtype GPCR families","volume":"51","author":"Ma","year":"2011","journal-title":"J Chem Inf Model"},{"key":"2021032314270801800_ref40","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1021\/ci3003914","article-title":"LiCABEDS II. Modeling of ligand selectivity for G-protein-coupled cannabinoid receptors","volume":"53","author":"Ma","year":"2013","journal-title":"J Chem Inf Model"},{"key":"2021032314270801800_ref41","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","article-title":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro","volume":"30","author":"Wang","year":"2020","journal-title":"Cell Res"},{"key":"2021032314270801800_ref42","article-title":"Identification of antiviral drug candidates against SARS-CoV-2 from FDA-approved drugs","author":"Jeon","year":"2020","journal-title":"bioRxiv"},{"key":"2021032314270801800_ref43","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0140-6736(20)31022-9","article-title":"Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial","volume":"395","author":"Wang","year":"2020","journal-title":"Lancet (London, England)"}],"container-title":["Briefings in Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/bib\/article-pdf\/22\/2\/882\/36655417\/bbaa155.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/bib\/article-pdf\/22\/2\/882\/36655417\/bbaa155.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,23]],"date-time":"2021-03-23T14:33:00Z","timestamp":1616509980000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bib\/article\/22\/2\/882\/5876604"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,27]]},"references-count":43,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,7,27]]},"published-print":{"date-parts":[[2021,3,22]]}},"URL":"https:\/\/doi.org\/10.1093\/bib\/bbaa155","relation":{},"ISSN":["1467-5463","1477-4054"],"issn-type":[{"type":"print","value":"1467-5463"},{"type":"electronic","value":"1477-4054"}],"subject":[],"published-other":{"date-parts":[[2021,3]]},"published":{"date-parts":[[2020,7,27]]}}}